| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |